NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma

NCT01894061 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Adult Giant Cell Glioblastoma
Adult Glioblastoma
Adult Gliosarcoma
Recurrent Adult Brain Tumor

Interventions

BIOLOGICAL: Bevacizumab
DEVICE: NovoTTF-l00A
OTHER: Quality of Life Assessment

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]